Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Memphasys Ltd ( (AU:MEM) ) has shared an announcement.
Memphasys Limited announced the resignation of Mr. Michael Atkins as Non-Executive Director due to competing time commitments. Mr. Atkins, who joined the board in March 2024, contributed significantly with his expertise in capital markets and corporate governance. The company expressed gratitude for his strategic insights during his tenure. To ensure continued growth and expertise in commercialisation and global market development, the board recently appointed Mr. Marjan Mikel, whose skill set complements the company’s strategic objectives in the reproductive health sector.
More about Memphasys Ltd
Memphasys Limited (ASX: MEM) is a biotechnology company specializing in advanced reproductive biotechnology. The company develops medical devices, diagnostics, and proprietary media for human and animal applications. Its flagship technologies, such as the Felix™ and RoXsta™ Systems, aim to deliver transformative solutions that enhance fertility outcomes worldwide.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$9.92M
See more data about MEM stock on TipRanks’ Stock Analysis page.